Variant report
Variant | esv3358946 |
---|---|
Chromosome Location | chr7:146417044-146420192 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs193254826 | chr7:146417097-146417098 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527429454 | chr7:146417125-146417126 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540727989 | chr7:146417141-146417142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563896889 | chr7:146417174-146417175 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs11341069 | chr7:146417223-146417224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs397888908 | chr7:146417232-146417233 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs532983696 | chr7:146417280-146417281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549787030 | chr7:146417297-146417298 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs148333850 | chr7:146417307-146417308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs529265246 | chr7:146417318-146417319 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs13231376 | chr7:146417326-146417327 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141449560 | chr7:146417338-146417339 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs150830199 | chr7:146417344-146417345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558300967 | chr7:146417354-146417355 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs571840928 | chr7:146417380-146417381 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs537677974 | chr7:146417396-146417397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs538178983 | chr7:146417404-146417405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557354439 | chr7:146417445-146417446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs62481396 | chr7:146417467-146417468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190290849 | chr7:146417482-146417483 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554893475 | chr7:146417491-146417492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138115471 | chr7:146417502-146417503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537719737 | chr7:146417511-146417512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs540688746 | chr7:146417515-146417516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181127237 | chr7:146417523-146417524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184122145 | chr7:146417524-146417525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs114400595 | chr7:146417525-146417526 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543644894 | chr7:146417535-146417536 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs73740818 | chr7:146417586-146417587 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs188124179 | chr7:146417611-146417612 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181023874 | chr7:146417666-146417667 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs566046354 | chr7:146417768-146417769 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528516787 | chr7:146417780-146417781 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs186100952 | chr7:146417785-146417786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs577621391 | chr7:146417858-146417859 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73168719 | chr7:146417865-146417866 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs191827387 | chr7:146417869-146417870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557578778 | chr7:146417871-146417872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs567761322 | chr7:146417876-146417877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs118105129 | chr7:146417890-146417891 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs73168722 | chr7:146417912-146417913 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs73168724 | chr7:146417921-146417922 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs534350834 | chr7:146417985-146417986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557422749 | chr7:146418013-146418014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577714630 | chr7:146418050-146418051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs369722560 | chr7:146418053-146418054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144102854 | chr7:146418055-146418056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182449287 | chr7:146418059-146418060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs71525965 | chr7:146418070-146418071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs71165032 | chr7:146418078-146418079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Pancreatitis | 21956041 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Gastric cancer | 16891809 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 20808228 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 20964600 | CNVD |
Epilepsy | 17646849 | CNVD |
Mental retardation | 19896112 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Glioma | 20126413 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:146410800-146417400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr7:146417000-146417800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr7:146417000-146417800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr7:146417400-146417600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr7:146417600-146417800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
6 | chr7:146417800-146422600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |